Delivery Order SPE2DB20D6037-SPE2DB25FTVZ6
- Not listed
- The Defense Logistics Agency awarded a $3,052.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Ondansetron ODT 4 mg tablets (30-count packaging) on August 12, 2025, with completion targeted for August 13, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this award,...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a ceiling value of $2,388.64. This firm fixed-price delivery order represents a continuation of the companies' established relationship under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and extending through November 2026. The contract involves no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,708.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Ondansetron HCL 4 mg tablets (30-count units). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, operates under a firm fixed-price structure with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.19 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 8 mg tablets (30-count packages) under a firm fixed-price contract type. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will be executed from Conshohocken, Pennsylvania. This delivery order was not issued under a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $8,789.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ondansetron HCl 4 mg tablets (500 count). The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,758.80 contract is for the delivery of ondansetron orally disintegrating tablets, 8 mg, in 30-count packages. DMS Pharmaceutical Group holds a larger indefinite delivery/indefinite quantity (ID/IQ) contract, number 4600082013, with the Defense Logistics Agency under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,814.73 on July 7, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) to support federal healthcare operations. This firm fixed-price delivery order carries an ultimate completion date of July 8, 2025, and does not utilize a set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,555.78 contract is for the delivery of ondansetron ODT 8 mg tablets to support military medical facilities worldwide. The delivery order is part of a larger $4,999,999 indefinite delivery contract (SPE2DB) with DMS Pharmaceutical Group to provide a broad range of pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB25FTVZ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,329.18 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor without a set-aside designation. The place of performance is identified as Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle valid through November 2026. The parent contract enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Ondansetron, a commonly used antiemetic medication, represents one of numerous pharmaceutical items available through this broad-based contracting vehicle, which covers prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 7/17/25 |